{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dementia+in+Parkinsons+Disease", "query": { "condition": "Dementia in Parkinsons Disease" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 75, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dementia+in+Parkinsons+Disease&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T10:23:24.589Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06644573", "title": "Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Insomnia", "Sleep Deprivation", "REM Behavior Disorder", "REM Sleep Behavior Disorder", "REM Sleep Measurement", "Insomnia", "Insomnia Related to Specified Disorder", "Insomnia Due to Other Mental Disorder", "Insomnia Comorbid to Psychiatric Disorder", "Insomnia Due to Anxiety and Fear", "Insomnia Related to Another Mental Condition", "Insomnia Disorders", "Idiopathic Hypersomnia", "Sleep Disorders, Circadian Rhythm", "Post Trauma Nightmares", "PTSD - Post Traumatic Stress Disorder", "Sleep Quality", "Anesthesia", "Anxiety", "Depression", "Mental Health", "Alzheimer Disease or Associated Disorder", "Parkinsons", "Circadian Rhythm", "Circadian Dysregulation", "PTSD", "Post-Traumatic", "Post-Traumatic Stress Disorder Complex", "Military Combat Stress Reaction", "Sleep", "Military Activity", "Veterans", "Shift Work Sleep Disorder", "Menopause Related Conditions", "Pain", "Cancer Pain", "Athletes" ], "interventions": [ { "name": "PROSOMNIA Sleep Therapy™ (PSTx)", "type": "PROCEDURE" }, { "name": "Anesthesia-Induced Sleep Therapy", "type": "PROCEDURE" }, { "name": "Diprivan (propofol), Astra-Zeneca", "type": "DRUG" }, { "name": "Continuous EEG Monitoring", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DEVICE" ], "sponsor": "Nyree Penn", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2025-11-01", "completion_date": "2026-05-01", "has_results": false, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "Aventura, Florida", "locations": [ { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06644573" }, { "nct_id": "NCT06445465", "title": "Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alpha-Synucleinopathy", "Parkinson's Disease", "Dementia With Lewy Bodies", "Multisystem Atrophy" ], "interventions": [ { "name": "[18F]MNI-1216", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Invicro", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 12, "start_date": "2020-12-24", "completion_date": "2024-11-26", "has_results": false, "last_update_posted_date": "2025-02-19", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06445465" }, { "nct_id": "NCT04148326", "title": "A Pilot Study to Explore the Role of Gut Flora in Parkinson's Disease", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease", "Parkinsons Disease With Dementia", "Parkinson-Dementia Syndrome", "Parkinson Disease 2", "Parkinson Disease 3", "Parkinson Disease 4" ], "interventions": [ { "name": "No Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "ProgenaBiome", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2020-03-02", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04148326" }, { "nct_id": "NCT01862744", "title": "Imaging Studies of Cognitive Impairment in Parkinson s Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease", "Dementia" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 76, "start_date": "2013-04-04", "completion_date": "2015-02-03", "has_results": false, "last_update_posted_date": "2019-12-12", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01862744" }, { "nct_id": "NCT02194816", "title": "Modifiable Variables in Parkinsonism (MVP)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease", "Parkinsonism", "MSA - Multiple System Atrophy", "Progressive Supranuclear Palsy", "Shy-Drager Syndrome", "Corticobasal Degeneration", "Dementia With Lewy Bodies", "Pick Disease", "Olivopontocerebellar Atrophies" ], "interventions": [], "intervention_types": [], "sponsor": "Bastyr University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 2000, "start_date": "2012-09", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2022-03-25", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "Kenmore, Washington", "locations": [ { "city": "Kenmore", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02194816" }, { "nct_id": "NCT01461109", "title": "Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson Disease", "Alzheimer Disease" ], "interventions": [ { "name": "[18F] CFPyPB", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Institute for Neurodegenerative Disorders", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 4, "start_date": "2011-08", "completion_date": "2014-05", "has_results": false, "last_update_posted_date": "2014-06-04", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01461109" }, { "nct_id": "NCT00294554", "title": "Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson's Disease", "Cognitive Impairment", "Dementia" ], "interventions": [ { "name": "Memantine", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 20, "start_date": "2006-04", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2017-09-12", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00294554" }, { "nct_id": "NCT02750982", "title": "Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer's Disease", "Amyotrophic Lateral Sclerosis", "Brain Injury", "Huntington's Disease", "Multiple Sclerosis", "Parkinson's Disease", "Stroke", "Spinal Cord Injury" ], "interventions": [ { "name": "Laughter Therapy", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brown, Theodore R., M.D., MPH", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2016-07", "completion_date": "2018-08", "has_results": false, "last_update_posted_date": "2018-09-26", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "Kirkland, Washington", "locations": [ { "city": "Kirkland", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02750982" }, { "nct_id": "NCT03938922", "title": "A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson Disease", "Dementia" ], "interventions": [ { "name": "Active Investigational Treatment ENT-01", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Enterin Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "30 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2024-03-01", "completion_date": "2025-12-15", "has_results": false, "last_update_posted_date": "2024-03-01", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 3, "location_summary": "Fresno, California • Toms River, New Jersey • Dayton, Ohio", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Toms River", "state": "New Jersey" }, { "city": "Dayton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03938922" }, { "nct_id": "NCT02103894", "title": "Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease (AD)", "Parkinson's Disease (PD)", "Chronic Traumatic Encephalopathy (CTE)", "Progressive Supranuclear Palsy (PSP)", "Frontal Temporal Dementia (FTD)", "Pick's Disease", "Tauopathies" ], "interventions": [ { "name": "[18F]T807 ([18F]MNI-777)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Molecular NeuroImaging", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2014-02", "completion_date": "2016-09", "has_results": false, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-06-10T10:23:24.589Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02103894" } ] }